ARCHIVES

Randomized Trials Discovered Roles For Newly Approved Nexavar and Sutent.

This article is from The Cancer Letter archive.

Vol. 32 No. 07 | February 24, 2006

Download PDF Visit The Full Archive

Related Articles

In Brief: Plastic Surgeon James French Named to NCAB; Clinton Re-Appoints Nienhuis

April 11, 2000

Abstract Of Papers Presented By Breast Cancer Task Force

September 24, 1976

NCI funds nine centers for $14.9 million integrative biology program.

October 29, 2004

In Brief :Three Named to Leadership Posts At St. Jude; Mitchell Weiss Appointed Chair of Hematology

June 11, 2014

Cancer Panel To Examine Health Of Phase I Trials

May 17, 1996

FDA Orders More Changes In ESA Label,

August 8, 2008